Nasal high flow oxygen therapy offers another option for patients requiring non-invasive respiratory support. Nasal high flow oxygen therapy allows delivery of a prescribed FiO2 with reduced air entrainment and dilution. This therapy may be beneficial in that nasal interfaces may be better tolerated and children receive the benefits of humidification and likely also receive a low level positive airway pressure.

The global High Flow Oxygen Cannula market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on High Flow Oxygen Cannula volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Flow Oxygen Cannula market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Fisher & Paykel Healthcare
Vapotherm
ResMed
Teleflex
Salter Labs
Flexicare
Great Group Medical
Smiths Medical
medin Medical Innovations
Armstrong Medical

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Pediatric
Adult

Segment by Application
Home Care
Hospitals
Ambulatory Surgical Centers